_ap_ufes{"success":true,"siteUrl":"www.investmentyogi.com/w","urls":{"Home":"http://www.investmentyogi.com","Category":"http://www.investmentyogi.com/category/alternative-investment/","Archive":"http://www.investmentyogi.com/2015/02/","Post":"http://www.investmentyogi.com/salient-aspects-of-union-budget-2015/","Page":"http://www.investmentyogi.com/nri/","Nav_menu_item":"http://www.investmentyogi.com/trending/","Wpcf7_contact_form":"http://www.investmentyogi.com/?post_type=wpcf7_contact_form&p=5591","Flare":"http://www.investmentyogi.com/flare/email/"}}_ap_ufee

Yogi Zone

Useful articles for your finance management by our team of experts

Cipla Stock Review – Nifty 50

0 Flares 0 Flares ×

Stock NameCipla Ltd

Listed Exchange: NSE, BSE

NSE Code- CIPLA

P/E or Price to Equity Ratio: 23.03

EPS or Earnings per Share: 18.15

P/B or Price to book value ratio: 3.78

Market Capitalization: Rs. 33,566.13 crore

Current Price on NSE – 418.05

52 Week Low – 354

52 Week High – 450

Our Review of Cipla Stock

Cipla is among the leading pharmaceutical companies in India. If you had invested in the stock in 2004, you would have invested at a level of 108, which means the stock has multiplied by nearly 4 times.

HDFC and Reliance funds together hold more than 70 lakh shares of Cipla. The stock has provided consistent returns. P/E ratio is attractive with good EPS. Loyal shareholders have made great wealth from this stock.

0 Flares Facebook 0 Google+ 0 Twitter 0 Email -- 0 Flares ×